Nelson memo

The Nelson Memo: Igniting a Global Open Data Revolution

The landscape of scientific research is undergoing a seismic shift, driven by an urgent demand for transparency, reproducibility, and equitable access. At the epicenter of this transformation in the United States is the Nelson Memo, a policy directive rapidly accelerating the future of open science. With the National Institutes of Health (NIH)'s recent announcement (NOT-OD-25-101)…...
Read More

Top Stories

MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
MAPS EMEA 2025

Amplifying the Patient Voice: Reflections from MAPS EMEA 2025

At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the...
Graphical or Visual Abstracts

Graphical Abstracts – Communicating Complex Information Visually

Three years ago, we explored how visual abstracts revolutionize research communication by transforming dense scientific findings into...
Global Capability Centers

Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence

As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability...

“Voice of Patient” in Publications: Trends and Perspectives

This page contains a poster presented at the 21st Annual Meeting of ISMPP (International Society for Medical Publication...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy

Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical...
Rare diseases

Rare Diseases – An Evolving Medical Communications Landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However...

Learn more ABOUT our company.